← Eichor
Study identifier: NCT05541601 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Prospective Cohort for Early Detection of Liver Cancer

Condition: Cirrhosis · Hepatocellular Carcinoma  ·  Sponsor: University of Oxford

PhaseN/A
Planned participants3000
Who can joinAll sexes, 18 Years to 100 Years
Healthy volunteersNo

About this study

This study aims to recruit 3000 people with liver cirrhosis into a Prospective cohort for early detection of Liver cancer - the Pearl cohort. The study team believe that using a combination of novel tests may improve the detection of early Hepatocellular Carcinoma (HCC).

This description comes directly from the study's public registry record.

Talk to the study team

Study Coordinator  ·  deliver-pearl@ndm.ox.ac.uk

Always discuss trial participation with your own doctor first.

Locations (1)

Hepatology Clinical Trial Unit, John Radcliffe HospitalOxford, Oxfordshire, United KingdomRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05541601